Rockwell Medical Inc. [NASDAQ: RMTI] stock went on an upward path that rose over 30.41% on Tuesday, amounting to a one-week price increase of more than 55.65%. The company report on February 9, 2021 that Rockwell Medical Announces U.S. Availability of Triferic® AVNU for Replacement of Iron and Maintenance of Hemoglobin in Patients on Hemodialysis.
Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and improving outcomes for patients around the world, announced that Triferic AVNU (ferric pyrophosphate citrate injection), the intravenous (IV) formulation of Triferic, is now available to patients in the United States. Triferic AVNU was approved by the U.S. Food and Drug Administration (FDA) in March 2020 and is indicated for the replacement of iron to maintain hemoglobin in adult patients with hemodialysis-dependent chronic kidney disease (HDD-CKD).
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
“The commercial availability of Triferic AVNU is good news for patients with chronic kidney disease on hemodialysis and their healthcare providers. This IV formulation is an important line extension of Triferic Dialysate,” said Russell Ellison, M.D., M.Sc., President and Chief Executive Officer of Rockwell Medical. “With Triferic AVNU, more patients will have access to the benefits of Triferic as providers will have added flexibility to administer the IV formulation to their patients who may benefit from physiologic iron maintenance therapy to manage their anemia.”.
Over the last 12 months, RMTI stock dropped by -19.58%. The average equity rating for RMTI stock is currently 2.00, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $179.34 million, with 93.57 million shares outstanding and 81.49 million shares in the current float. Compared to the average trading volume of 1.54M shares, RMTI stock reached a trading volume of 13234705 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Rockwell Medical Inc. [RMTI]:
Piper Jaffray have made an estimate for Rockwell Medical Inc. shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on June 24, 2019. While these analysts kept the previous recommendation, H.C. Wainwright raised their target price to Buy. The new note on the price target was released on May 13, 2019, representing the official price target for Rockwell Medical Inc. stock.
The Average True Range (ATR) for Rockwell Medical Inc. is set at 0.13, with the Price to Sales ratio for RMTI stock in the period of the last 12 months amounting to 2.87. The Price to Book ratio for the last quarter was 3.27, with the Price to Cash per share for the same quarter was set at 0.72.
RMTI Stock Performance Analysis:
Rockwell Medical Inc. [RMTI] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 55.65. With this latest performance, RMTI shares gained by 75.45% in over the last four-week period, additionally plugging by 11.56% over the last 6 months – not to mention a drop of -19.58% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for RMTI stock in for the last two-week period is set at 81.92, with the RSI for the last a single of trading hit 86.60, and the three-weeks RSI is set at 78.01 for Rockwell Medical Inc. [RMTI]. The present Moving Average for the last 50 days of trading for this stock 1.1761, while it was recorded at 1.4860 for the last single week of trading, and 1.4815 for the last 200 days.
Insight into Rockwell Medical Inc. Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and Rockwell Medical Inc. [RMTI] shares currently have an operating margin of -55.62 and a Gross Margin at +4.63. Rockwell Medical Inc.’s Net Margin is presently recorded at -55.67.
Return on Total Capital for RMTI is now -132.07, given the latest momentum, and Return on Invested Capital for the company is -138.23. Return on Equity for this stock declined to -143.41, with Return on Assets sitting at -70.46. When it comes to the capital structure of this company, Rockwell Medical Inc. [RMTI] has a Total Debt to Total Equity ratio set at 19.87. Additionally, RMTI Total Debt to Total Capital is recorded at 16.58, with Total Debt to Total Assets ending up at 9.11. Long-Term Debt to Equity for the company is recorded at 8.76, with the Long-Term Debt to Total Capital now at 7.31.
Reflecting on the efficiency of the workforce at the company, Rockwell Medical Inc. [RMTI] managed to generate an average of -$114,141 per employee. Receivables Turnover for the company is 10.61 with a Total Asset Turnover recorded at a value of 1.27.Rockwell Medical Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 5.80 and a Current Ratio set at 6.10.
RMTI Stock EPS
With the latest financial reports released by the company, Rockwell Medical Inc. posted -0.11/share EPS, while the average EPS was predicted by analysts to be reported at -0.12/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 8.30%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for RMTI. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Rockwell Medical Inc. go to 38.00%.
Rockwell Medical Inc. [RMTI] Insider Position Details
There are presently around $50 million, or 45.10% of RMTI stock, in the hands of institutional investors. The top three institutional holders of RMTI stocks are: CVI HOLDINGS, LLC with ownership of 5,301,527, which is approximately New of the company’s market cap and around 0.30% of the total institutional ownership; BLACKROCK INC., holding 4,790,950 shares of the stock with an approximate value of $9.25 million in RMTI stocks shares; and SABBY MANAGEMENT, LLC, currently with $6.94 million in RMTI stock with ownership of nearly New of the company’s market capitalization.
Positions in Rockwell Medical Inc. stocks held by institutional investors increased at the end of March and at the time of the March reporting period, where 42 institutional holders increased their position in Rockwell Medical Inc. [NASDAQ:RMTI] by around 11,412,514 shares. Additionally, 41 investors decreased positions by around 1,190,015 shares, while 19 investors held positions by with 13,324,782 shares. The mentioned changes placed institutional holdings at 25,927,311 shares, according to the latest SEC report filing. RMTI stock had 19 new institutional investments in for a total of 9,482,250 shares, while 14 institutional investors sold positions of 342,075 shares during the same period.